Previous 10 | Next 10 |
2024-06-11 05:50:00 ET Johnson & Johnson reigned as the largest healthcare company in the world for years. UnitedHealth Group also took a turn at the top. However, the title now belongs to Eli Lilly (NYSE: LLY) -- and it isn't even close. Lilly continues to widen its...
2024-06-10 20:52:27 ET The biotech sector includes companies that develop drugs and diagnostic technologies based on biology. These firms often focus on developing innovative treatments for various medical conditions. Investments in this sector are driven by the potential for significant br...
2024-06-10 20:20:28 ET Eli Lilly and Company (LLY) Goldman Sachs 45th Annual Global Healthcare Conference June 10, 2024 4:00 PM ET Company Participants Patrik Jonsson - Executive Vice President, President of Lilly Diabetes and Obesity and Lilly USA Conference Call ...
2024-06-10 20:17:47 ET Alzheimer’s could eventually be a “very big category” for Eli Lilly & Co (NYSE: LLY), says Dr Scott Gottlieb. He’s the former commission of the U.S. Food & Drug Administration. FDA advisors vote in favour of Lilly’s d...
A look at the top 10 most actives in the United States KWESST Micro Systems Inc. (KWE) rose 117.2% to $0.8686 on volume of 324,599,275 shares NVIDIA Corporation (NVDA) rose 0.7% to $121.79 on volume of 306,257,100 shares Nauticus Robotics Inc. (KITT) rose 49.0% to $0.2309 on volume of 208...
2024-06-10 15:35:10 ET More on Eli Lilly Lilly's donanemab, remternetug set to dominate Alzheimer's treatment by 2030 Is It Possible Eli Lilly Is Breaking Out To New All-Time Highs? Eli Lilly's Growth And Challenges: A Cautious Buy Weight loss drugs other ben...
2024-06-10 14:55:09 ET Summary Coya Therapeutics is set to initiate a Phase 2 trial in ALS and release the topline results of a Phase 2 trial in Alzheimer's disease in the summer. The company's anti-inflammatory approach has received strong external validation. Recently, small...
2024-06-10 14:38:05 ET More on Eli Lilly, Novo Nordisk SA Asks: Is Eli Lilly or Novo Nordisk a better investment? Is It Possible Eli Lilly Is Breaking Out To New All-Time Highs? Eli Lilly's Growth And Challenges: A Cautious Buy SA Asks: Which weight-los...
2024-06-10 12:48:37 ET Summary Five Keros Therapeutics, Inc. abstracts are expected at the upcoming EHA conference between June 13th -16th of 2024, showcasing data using KER-050 for the treatment of patients with low-risk myelodysplastic syndrome. The company has already met with ...
2024-06-10 12:09:47 ET More on Biogen, Eisai , etc. Biogen Inc. (BIIB) Q1 2024 Earnings Call Transcript Eisai Co Ltd. (ESALF) Q4 2024 Earnings Call Transcript Biogen: Reasons To Be Cheerful After Upbeat Q1 Earnings Lilly's donanemab, remternetug set to d...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 05:48:00 ET Novo Nordisk (NYSE: NVO) is riding the Ozempic/Wegovy train straight to the bank. Eli Lilly (NYSE: LLY) is doing the same with Mounjaro and Zepbound. Both big drugmakers have multibillion-dollar obesity drug franchises that continue to grow rapidly. Sh...
2024-07-18 05:23:00 ET Stock splits can sometimes be an effective way for a company to generate excitement around its stock. It's a sign that the company is doing well, and by lowering the price of the stock through a split, the shares can become more accessible to a wider pool of investo...
2024-07-17 13:21:54 ET Shares of Swiss pharmaceuticals company Roche Holding (OTC: RHHBY) soared 7% through 11:55 a.m. ET Wednesday on positive data from phase 1 clinical trials of its new weight loss drug CT-996. But good news for Roche is bad news for the companies that no...